Purchases and Sales Made in Q4 2023 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q4 2023. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
70.9KNew |
$31.9K - $63.8K
|
70.9K
$117K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
63.7K+ 884.93% |
$28.7K - $57.3K
|
70.9K
$117K
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
56.3KNew |
$25.3K - $50.7K
|
56.3K
$92.9K
|
|
|
Feb 14, 2024
Q4 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
35.4KNew |
$15.9K - $31.9K
|
35.4K
$58.4K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
32.7KNew |
$14.7K - $29.4K
|
32.7K
$53.9K
|
|
|
Feb 13, 2024
Q4 2023
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
29KNew |
$13.1K - $26.1K
|
29K
$47.9K
|
|
|
Feb 26, 2024
Q4 2023
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
25.8KNew |
$11.6K - $23.2K
|
25.8K
$42.6K
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
19.7KNew |
$8.87K - $17.7K
|
19.7K
$32.5K
|
|
|
Feb 08, 2024
Q4 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
15.8K+ 555.19% |
$7.1K - $14.2K
|
18.6K
$30.7K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 12, 2024
Q4 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-1.19K- 67.04% |
$536 - $1.07K
|
585
$965
|